You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Multiscale Software Tool for Field/Circuit Simulation

    SBC: WAVE COMPUTATION TECHNOLOGIES INC            Topic: A08T004

    Wave Computation Technologies, Inc. (WCT) proposes to develop a new multiscale solver for electromagnetic field/circuit co-simulation. This solver combines three efficient electromagnetic field algorithms, (a) the spectral element time-domain (SETD) metho

    STTR Phase II 2009 Department of DefenseArmy
  2. A Novel Drug for Septicemia Targets A1 ARs

    SBC: ENDACEA, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Despite the availability of newer antimicrobial agents, improved supportive care, and the introduction of an FDA approved adjunctive therapy for sepsis, (Xigris(r), drotrecogin alfa), the mortality rate for severe sepsis and septic shock of 30-60% remains high. Endacea, Inc. (Research Triangle Park, NC) approaches sepsis with a proprietary diagnostic/biomarker ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  3. A Novel Therapy for Staphylococcal Enterotoxin B Poisoning

    SBC: SOYMEDS INC            Topic: N/A

    DESCRIPTION (provided by applicant): Staphylococcus aureus is a significant human pathogen which can produce a variety of toxins, including the exotoxin, staphylococcal enterotoxin B (SEB). SEB is highly toxic in small doses, and the compact structure of this protein makes it resistant to heat and denaturation. The combination of toxicity and stability caused this toxin to be selected for weaponiz ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  4. A Universal Brain Atlas for Implanting and Managing Deep Brain Stimulators

    SBC: Neurotargeting, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Neurotargeting, LLC proposes to develop the technical support infrastructure as well as clinical tools for a commercial software product that will provide a global service for the medical community involved in deep brain stimulator (DBS) therapy. Specifically, this Phase I study will explore the use of a physiological atlas database that can interface with a nu ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  5. Development of ADAM10 Prodomain as a Therapeutic Agent

    SBC: BIOZYME, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Recent cancer therapies have focused on using biologics to target specific signal transduction pathways implicated in the tumor development or progression. For example, recombinant fusion proteins consisting of the extracellular domain of the immunoregluatory proteins and the constant (Fc) domain of immunoglobulin (IgG) represent a growing class of protein ther ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  6. Development of a Novel Method for Inhibiting Atherosclerosis in Diabetes

    SBC: VASCULAR PHARMACEUTICALS            Topic: N/A

    DESCRIPTION (provided by applicant): The long term objective of the proposed studies is to develop a monoclonal antibody that can be administered safely to patients with diabetes that will inhibit atherosclerosis. Insulin-like growth factor-I has been implicated in the initiation of the proliferative phase of atherosclerotic lesion development but inhibiting IGF-I receptor activity may lead to tox ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  7. Development of Multidisciplinary, Multi-Fidelity Analysis and Integration of Aerospace Vehicles

    SBC: VEXTEC Corporation            Topic: AF08BT03

    Current aircraft design approaches incorporate the use of many high fidelity models for point solutions of individual disciplines. Sophisticated model integration techniques are not yet readily available and a significant amount of individual discipline stovepiping exists. Individual handoffs of point solutions between disciplines often results in repeated individual data interpretations.  These ...

    STTR Phase I 2009 Department of DefenseAir Force
  8. Development of Multi-layer Aluminum Alloys for Armor

    SBC: TOUCHSTONE RESEARCH LABORATORY, LTD.            Topic: A09AT010

    The proposed STTR Phase I study is aimed at exploring lightweight and multi-layer materials towards enhancing their armor performance. Different Al alloys will be assembled into a two-layer configuration with good metallic bond between inter-layers. 2139-T8 Al alloy evolved by efforts of Alcan and the Army Research Laboratory will be selected as one of the layers in the laminated assembly. 5083, 7 ...

    STTR Phase I 2009 Department of DefenseDefense Advanced Research Projects Agency
  9. Electrical power generation for sustained high speed flight

    SBC: RIVIS, INC.            Topic: AF08BT25

    Development of a compliant microfabricated heat exchanger to work with thermoelectric devices as a means of power generation for hypersonic vehicles is proposed. Polymer-based materials provide to provide compression on the thermoelectric module, to ensure optimal thermal contact, while allowing for compliance to allow for the change in materials expansion without exceeding the failure point of th ...

    STTR Phase I 2009 Department of DefenseAir Force
  10. Fast Spectral Imaging Device For Tumor Margin Mapping

    SBC: Zenalux Biomedical, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The American Cancer Society estimates that a total of 240,430 new breast cancers were diagnosed in 2007 (178,400 new cases of invasive breast cancer, and 62,030 new cases of in situ breast cancer). Approximately 180,000 of these patients undergo breast conserving surgery (BCS), also called lumpectomy. Multiple recent studies show that a staggering 20-70% of the ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government